filmov
tv
Tech Future Facts Podcast: Ekso Bionics (EKSO)
Показать описание
Ekso Bionics: A Leader in the Exoskeleton Revolution
Have you ever imagined technology that could help people walk again, or even give factory workers superhuman strength? Well, that technology already exists, and Ekso Bionics (EKSO on the stock market) is at the forefront of this exciting field.
Ekso Bionics develops exoskeletons – wearable machines that augment human movement and capabilities. Today, we'll delve into Ekso Bionics' strategic position and the vast market opportunity they represent.
Disclaimer:
The information contained in this podcast is for informational purposes only and should not be construed as financial advice. Ekso Bionics is a publicly traded company (EKSO on the stock market). This podcast does not constitute an offer to buy or sell any securities, and it does not constitute a recommendation of any particular investment. Investors should conduct their own due diligence before making any investment decisions.
Ekso Bionics neurorehabilitation products are medical devices and proper medical evaluation and prescription are required. Please consult with a qualified healthcare professional to determine if an Ekso Bionics product is right for you.
A Booming Market: Neurorehabilitation and Industrial Applications
Ekso Bionics caters to two distinct, yet rapidly growing markets: neurorehabilitation and industrial use.
Neurorehabilitation: For individuals with neurological conditions like spinal cord injuries, strokes, or multiple sclerosis, Ekso Bionics' exoskeletons provide crucial support during physical therapy. These devices can help patients regain lost mobility, improve coordination, and rebuild muscle strength.
Spinal Cord Injuries (SCI):
Globally, estimates range from 250,000 to 500,000 new cases of SCI annually according to the World Health Organization (WHO).
Traumatic Brain Injuries (TBI):
The Centers for Disease Control and Prevention (CDC) reports that in the US, there are an estimated 1.5 million TBIs sustained each year.
Industrial Applications: Ekso Bionics' industrial exoskeletons empower workers in physically demanding jobs. These exoskeletons can reduce strain on the back and limbs, preventing injuries and promoting worker safety. They can also amplify a worker's strength and endurance, potentially increasing productivity.
The global exoskeleton market is expected to reach a staggering $10.6 billion by 2030. Ekso Bionics, with its established customer base and proven technology, is perfectly positioned to capitalize on this immense growth.
Ekso Indego Personal: Changing Lives after Spinal Cord Injury
Ekso Bionics isn't just about science fiction; it's about real-world impact. Their Ekso Indego Personal exoskeleton is a game-changer for people with spinal cord injuries (SCI). This device helps individuals regain mobility and improve their quality of life.
Here's the exciting news: As of April 1st, 2024, Medicare will reimburse healthcare providers $91,031.93 for the Ekso Indego Personal. This significantly reduces the financial burden for patients with SCI who can benefit from this life-changing technology.
Imagine being able to walk again after an accident. The Ekso Indego Personal makes that dream a reality for many. It's lightweight, portable, and allows users to achieve faster walking speeds, fostering greater independence.
We previously discussed how Ekso Bionics is revolutionizing movement through their innovative exoskeletons. But Ekso Bionics isn't just about a single product; they offer a comprehensive solution for the entire neurorehabilitation journey.
The Neurorehabilitation Continuum: A Long Road to Recovery
Neurorehabilitation is a complex process that can take months or even years. It involves a continuum of care, starting in specialized facilities and gradually transitioning to home-based recovery. Ekso Bionics' exoskeletons are designed to support patients throughout this entire journey.
Phase 1: Intensive Therapy in Rehab Centers
The initial phase of neurorehabilitation typically takes place in a specialized inpatient or outpatient rehabilitation center. Here, patients undergo intensive physical and occupational therapy to regain lost skills and improve function.
Ekso Bionics' Ekso NR exoskeleton is a powerful tool for therapists during this critical phase. The Ekso NR provides dynamic walking assistance and allows for gait pattern customization, helping patients relearn proper walking mechanics and build muscle strength.
Phase 2: Independent Living with Ekso Indego Personal
The ultimate goal of neurorehabilitation is for patients to achieve a high level of independence. This is where the Ekso Indego Personal truly shines.
Have you ever imagined technology that could help people walk again, or even give factory workers superhuman strength? Well, that technology already exists, and Ekso Bionics (EKSO on the stock market) is at the forefront of this exciting field.
Ekso Bionics develops exoskeletons – wearable machines that augment human movement and capabilities. Today, we'll delve into Ekso Bionics' strategic position and the vast market opportunity they represent.
Disclaimer:
The information contained in this podcast is for informational purposes only and should not be construed as financial advice. Ekso Bionics is a publicly traded company (EKSO on the stock market). This podcast does not constitute an offer to buy or sell any securities, and it does not constitute a recommendation of any particular investment. Investors should conduct their own due diligence before making any investment decisions.
Ekso Bionics neurorehabilitation products are medical devices and proper medical evaluation and prescription are required. Please consult with a qualified healthcare professional to determine if an Ekso Bionics product is right for you.
A Booming Market: Neurorehabilitation and Industrial Applications
Ekso Bionics caters to two distinct, yet rapidly growing markets: neurorehabilitation and industrial use.
Neurorehabilitation: For individuals with neurological conditions like spinal cord injuries, strokes, or multiple sclerosis, Ekso Bionics' exoskeletons provide crucial support during physical therapy. These devices can help patients regain lost mobility, improve coordination, and rebuild muscle strength.
Spinal Cord Injuries (SCI):
Globally, estimates range from 250,000 to 500,000 new cases of SCI annually according to the World Health Organization (WHO).
Traumatic Brain Injuries (TBI):
The Centers for Disease Control and Prevention (CDC) reports that in the US, there are an estimated 1.5 million TBIs sustained each year.
Industrial Applications: Ekso Bionics' industrial exoskeletons empower workers in physically demanding jobs. These exoskeletons can reduce strain on the back and limbs, preventing injuries and promoting worker safety. They can also amplify a worker's strength and endurance, potentially increasing productivity.
The global exoskeleton market is expected to reach a staggering $10.6 billion by 2030. Ekso Bionics, with its established customer base and proven technology, is perfectly positioned to capitalize on this immense growth.
Ekso Indego Personal: Changing Lives after Spinal Cord Injury
Ekso Bionics isn't just about science fiction; it's about real-world impact. Their Ekso Indego Personal exoskeleton is a game-changer for people with spinal cord injuries (SCI). This device helps individuals regain mobility and improve their quality of life.
Here's the exciting news: As of April 1st, 2024, Medicare will reimburse healthcare providers $91,031.93 for the Ekso Indego Personal. This significantly reduces the financial burden for patients with SCI who can benefit from this life-changing technology.
Imagine being able to walk again after an accident. The Ekso Indego Personal makes that dream a reality for many. It's lightweight, portable, and allows users to achieve faster walking speeds, fostering greater independence.
We previously discussed how Ekso Bionics is revolutionizing movement through their innovative exoskeletons. But Ekso Bionics isn't just about a single product; they offer a comprehensive solution for the entire neurorehabilitation journey.
The Neurorehabilitation Continuum: A Long Road to Recovery
Neurorehabilitation is a complex process that can take months or even years. It involves a continuum of care, starting in specialized facilities and gradually transitioning to home-based recovery. Ekso Bionics' exoskeletons are designed to support patients throughout this entire journey.
Phase 1: Intensive Therapy in Rehab Centers
The initial phase of neurorehabilitation typically takes place in a specialized inpatient or outpatient rehabilitation center. Here, patients undergo intensive physical and occupational therapy to regain lost skills and improve function.
Ekso Bionics' Ekso NR exoskeleton is a powerful tool for therapists during this critical phase. The Ekso NR provides dynamic walking assistance and allows for gait pattern customization, helping patients relearn proper walking mechanics and build muscle strength.
Phase 2: Independent Living with Ekso Indego Personal
The ultimate goal of neurorehabilitation is for patients to achieve a high level of independence. This is where the Ekso Indego Personal truly shines.
0:08:06
0:00:35
0:03:44
0:02:34
0:43:21
0:05:42
0:00:38
0:26:55
0:24:52
0:47:04
0:02:27
0:11:16
0:03:05
0:41:28
0:22:36
0:16:25